MYC and osteosarcoma: In our study, diosmetin inhibited tumor cell proliferation and promoted apoptosis as well as suppressed STAT3/c-Myc signaling pathway in osteosarcoma cells, which is consistent with the inhibitory effects of another STAT3 inhibitor toosendanin on cell proliferation of osteosarcoma 143B Cells [23].